VVOS · Vivos Therapeutics, Inc.
AI read · Neutral
The AI's read
This helps Vivos on one Nasdaq listing test, but it does not settle whether the company can stay listed. It must show it still meets the equity rule in its next report, or it may face delisting. The filing does not say whether it meets the other listing tests, and Nasdaq or its auditor could disagree about its accounting or equity.